Paul-Ehrlich-Institut

Go to:

You are here

Coronavirus and COVID-19

Pagination

COVID-19 Vaccines

Professor Klaus Cichutek explains: Coronavirus vaccine (German only)

Source: Federal Ministry of Health

Overview of COVID-19 Vaccines

Authorised COVID-19 Vaccines
WHO - Draft Landscape of COVID-19 Candidate Vaccines
COVID-19 Vaccines – Overview of Vaccine Types Authorised or in the Process of Authorisation in Europe

Infographic

Source: Paul-Ehrlich-Institut

European Commission Grants Conditional Marketing Authorisation for COVID-19 Vaccine by Janssen-Cilag N.V. for the European Union
Committee for Medicinal Products for Human Use (CHMP) Recommends Conditional Marketing Authorisation of the COVID-19 Vaccine by Janssen-Cilag International N.V.
Rolling Review Procedure started for the COVID-19 Vaccine Candidate Sputnik V from Russia at the European Medicines Agency
Janssen-Cilag International N.V. applies for a Conditional Marketing Authorisation of its COVID-19 Vaccine
CHMP starts Rolling Review for the first Virus-like Particle Vaccine against COVID-19
European Medicines Agency (EMA) has started Fourth Rolling Review of a COVID-19 Vaccine Candidate for Europe
European Commission grants conditional marketing authorisation for COVID-19 Vaccine Astra Zeneca for the European Union
Committee for Medicinal Products for Human Use Recommends Conditional Marketing Authorisation for the COVID-19 Vaccine from AstraZeneca
EMA receives Application for Conditional Marketing Authorisation of COVID-19 Vaccine of AstraZeneca
EMA information – Extra dose from vials of Comirnaty COVID-19- vaccine
European Commission Grants Marketing Authorisation for COVID-19 Vaccine from Moderna for the European Union
EMA’s Committee for Medicinal Products for Human Use recommends Conditional Marketing Authorisation for Moderna’s COVID-19 Vaccine
Paul-Ehrlich-Institut Releases First Batches of BioNTech/Pfizer's COVID-19 Vaccine Comirnaty for German and European Markets
European Commission grants Marketing Authorisation for BioNTech/Pfizer's COVID-19 Vaccine for the European Union
The Committee for Medicinal Products for Human Use at the EMA recommends Conditional Marketing Authorisation for the COVID-19 Vaccine from BioNTech/Pfizer
Authorisation of a COVID-19 Vaccine in the UK
European Medicines Agency EMA has Launched Third Rolling Review of a COVID-19 Vaccine Candidate for the EU
European Medicines Agency (EMA) has started Second Rolling Review Procedure of a COVID-19 Vaccine Candidate for Europe
European Medicines Agency (EMA) has started First Rolling Review Procedure of a COVID-19 Vaccine for Europe

Regulatory Response to SARS-CoV-2 Mutations

SafeVac 2.0 – Smartphone App to Survey Tolerability of COVID-19 Vaccines

Content

Navigation

You are here:

Newsroom
Coronavirus and COVID-19
Coronavirus and COVID-19